Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Hong Liu

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
The American Journal of Gastroenterology|February 8, 2019
Menopausal Hormone Therapy and Risk of DiverticulitisManol Jovani, Wenjie Ma, Amit D Joshi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinomaPo-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, et al.
BMC Cancer|March 16, 2018
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinomaChia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, et al.
The American Journal of Gastroenterology|September 6, 2018
Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort StudyPo-Hong Liu, Benjamin Lebwohl, Kristin E Burke, et al.
Scandinavian Journal of Gastroenterology|July 13, 2022
Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI gradeShu-Yein Ho, Mei-Hsia Yuan, Po-Hong Liu, et al.
Scientific Reports|March 5, 2020
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Clinical Gastroenterology|April 10, 2014
Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analysesYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.
American Journal of Clinical Oncology|July 24, 2019
An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan CriteriaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastroenterology and Hepatology|October 4, 2016
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD EraPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
The American Journal of Gastroenterology|February 8, 2019
Menopausal Hormone Therapy and Risk of DiverticulitisManol Jovani, Wenjie Ma, Amit D Joshi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinomaPo-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, et al.
BMC Cancer|March 16, 2018
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinomaChia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, et al.
The American Journal of Gastroenterology|September 6, 2018
Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort StudyPo-Hong Liu, Benjamin Lebwohl, Kristin E Burke, et al.
Scandinavian Journal of Gastroenterology|July 13, 2022
Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI gradeShu-Yein Ho, Mei-Hsia Yuan, Po-Hong Liu, et al.
Scientific Reports|March 5, 2020
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Clinical Gastroenterology|April 10, 2014
Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analysesYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.
American Journal of Clinical Oncology|July 24, 2019
An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan CriteriaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastroenterology and Hepatology|October 4, 2016
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD EraPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Pageof 9